ADGI Market Cap History
Below is a table of the ADGI market cap history going back to 9/13/2021:

Date ADGI Market Cap
9/13/20214.78B
11/8/20212.14B
3/24/2022460.64M
5/6/2022315.98M
8/8/2022427.70M

Also see: ADGI Shares Outstanding History
and ADGI YTD Return
ADGI Historical Market Cap:
-101.02% CAGR
ADGI Historical Market Cap: +-101.02% CAGR

Mouse over chart for data details
9/13/202111/8/20213/24/20225/6/20228/8/2022
Adagio Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of differentiated products for the prevention and treatment of infectious disease. Co. is developing its primary product candidate, adintrevimab, for the prevention and treatment of coronavirus disease 2019 (COVID-19), the disease caused by the virus SARS-CoV-2 and its variants. Adintrevimab is designed to be a neutralizing antibody for both the prevention and treatment of COVID-19. Co. is also evaluating additional neutralizing antibodies targeting the receptor binding domain, as well as other subdomains within the spike protein for COVID-19. We show 5 historical shares outstanding datapoints in our ADGI shares outstanding history coverage, used to compute ADGI market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ADGI market cap history over the course of time is important for investors interested in comparing ADGI's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ADGI versus a peer is one thing; comparing ADGI market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ADGI can fluctuate over the course of history. With this page we aim to empower investors researching ADGI by allowing them to research the ADGI market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ADGI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Adagio Therapeutics (ADGI) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ADIL Market Cap History
ADMA Market Cap History
ADMP Market Cap History
ADMS Market Cap History
ADPT Market Cap History
ADRO Market Cap History
ADTX Market Cap History
ADUS Market Cap History
ADVM Market Cap History
ADXS Market Cap History
More Healthcare companies »

 

ADGI Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.